Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CollaGenex (CGPI) FDA PENDING -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (120)	6/6/2005 9:32:52 AM
From: Gator II	Read Replies (1) \| Respond to of 142

The Oracea and once daily new should help CollaGenex recover some of the ground lost over the past year. The once daily formation should also help keep the generic predators at bay, too. It will be interesting to see how the market responds to this news. I'm betting that before year end the price will be north of $10 again but I'm getting gun shy. Anything can happen with the new management. My confidence is not as high as it once was. That might be a good sign. Gator II